» Articles » PMID: 38194643

Magnetic Resonance Imaging-Based Assessment of Pancreatic Fat Strongly Correlates With Histology-Based Assessment of Pancreas Composition

Abstract

Objective: The aim of the study is to assess the relationship between magnetic resonance imaging (MRI)-based estimation of pancreatic fat and histology-based measurement of pancreatic composition.

Materials And Methods: In this retrospective study, MRI was used to noninvasively estimate pancreatic fat content in preoperative images from high-risk individuals and disease controls having normal pancreata. A deep learning algorithm was used to label 11 tissue components at micron resolution in subsequent pancreatectomy histology. A linear model was used to determine correlation between histologic tissue composition and MRI fat estimation.

Results: Twenty-seven patients (mean age 64.0 ± 12.0 years [standard deviation], 15 women) were evaluated. The fat content measured by MRI ranged from 0% to 36.9%. Intrapancreatic histologic tissue fat content ranged from 0.8% to 38.3%. MRI pancreatic fat estimation positively correlated with microanatomical composition of fat (r = 0.90, 0.83 to 0.95], P < 0.001); as well as with pancreatic cancer precursor ( r = 0.65, P < 0.001); and collagen ( r = 0.46, P < 0.001) content, and negatively correlated with pancreatic acinar ( r = -0.85, P < 0.001) content.

Conclusions: Pancreatic fat content, measurable by MRI, correlates to acinar content, stromal content (fibrosis), and presence of neoplastic precursors of cancer.

Citing Articles

3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structure.

Kiemen A, Almagro-Perez C, Matos V, Forjaz A, Braxton A, Dequiedt L bioRxiv. 2024; .

PMID: 39149369 PMC: 11326156. DOI: 10.1101/2024.08.03.606493.


Power-law growth models explain incidences and sizes of pancreatic cancer precursor lesions and confirm spatial genomic findings.

Kiemen A, Wu P, Braxton A, Cornish T, Hruban R, Wood L Sci Adv. 2024; 10(30):eado5103.

PMID: 39058773 PMC: 11277401. DOI: 10.1126/sciadv.ado5103.


PanIN or IPMN? Redefining Lesion Size in 3 Dimensions.

Kiemen A, Dequiedt L, Shen Y, Zhu Y, Matos-Romero V, Forjaz A Am J Surg Pathol. 2024; 48(7):839-845.

PMID: 38764379 PMC: 11189722. DOI: 10.1097/PAS.0000000000002245.


The role of biomarkers in the early detection of pancreatic cancer.

Goggins M Fam Cancer. 2024; 23(3):309-322.

PMID: 38662265 PMC: 11309746. DOI: 10.1007/s10689-024-00381-4.


Three-dimensional assessments are necessary to determine the true, spatially-resolved composition of tissues.

Forjaz A, Vaz E, Romero V, Joshi S, Braxton A, Jiang A bioRxiv. 2023; .

PMID: 38106231 PMC: 10723352. DOI: 10.1101/2023.12.04.569986.